Morgan Stanley Asia
Description
Morgan Stanley Private Equity Asia (MSPEA) is the dedicated private equity investment arm of Morgan Stanley, primarily focused on the dynamic Asia-Pacific region. Established as a significant player in the private equity landscape, MSPEA specializes in making control and significant minority investments in well-established companies. Its strategy revolves around partnering with strong management teams to drive growth and operational improvements, leveraging Morgan Stanley's extensive global network and resources. The firm targets businesses with proven track records and substantial growth potential across various sectors, aiming for long-term value creation.
MSPEA's investment mandate spans a diverse range of industries, including consumer, healthcare, manufacturing, financial services, and technology. Geographically, its focus is broad within Asia, encompassing key markets such as China, India, Korea, Southeast Asia, Australia, and Japan. The team's deep regional expertise and local presence enable them to identify compelling investment opportunities and navigate complex market dynamics. They typically seek companies that are leaders or strong contenders within their respective niches, capable of benefiting from strategic capital infusion and operational enhancement.
The firm manages substantial capital, reflecting its significant presence in the Asian private equity market. For instance, its fifth flagship fund, Morgan Stanley Private Equity Asia V, successfully closed in 2018 with commitments totaling approximately $1.7 billion. This capital is deployed into a portfolio of companies, with typical first cheque sizes ranging from approximately $50 million to $250 million, depending on the specific opportunity and the equity stake sought. MSPEA targets companies that are poised for significant expansion, often through market consolidation, product innovation, or geographic expansion.
MSPEA's long-standing commitment to the Asia-Pacific market, coupled with its robust financial backing and strategic approach, positions it as a prominent investor for mature, high-growth companies in the region. The firm's ability to provide both capital and strategic guidance makes it a preferred partner for businesses seeking to scale and achieve their next phase of development.
Investor Profile
Morgan Stanley Asia has backed more than 40 startups, with 3 new investments in the last 12 months alone. The firm has led 15 rounds, about 38% of its total and boasts 25 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Post Ipo Secondary, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in India, China, Hong Kong.
- Strong thematic focus on Manufacturing, Financial Services, Health Care.
- Typical check size: $50M – $250M.
Stage Focus
- Private Equity (43%)
- Post Ipo Secondary (28%)
- Post Ipo Equity (23%)
- Undisclosed (3%)
- Series D (3%)
- Seed (3%)
Country Focus
- India (55%)
- China (18%)
- Hong Kong (8%)
- Taiwan (5%)
- South Korea (5%)
- United Arab Emirates (3%)
- United States (3%)
- Austria (3%)
- Singapore (3%)
Industry Focus
- Manufacturing
- Financial Services
- Health Care
- Finance
- Real Estate
- Insurance
- Wellness
- Health Insurance
- Banking
- E-commerce
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.